# History and Physical

> **SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD**

- Patient: Sun Yat-sen (real historical name used in a fictional teaching record)
- Synthetic MRN: HR-ET016-SYN
- Date: 2026-05-04
- Fictional facility: St. Posthumous Health Center
- Fictional author: Wen-Li Huang, MD
- Calendar frame: modern shifted

## Reason for visit

New patient with a right upper abdominal mass, aching and weight loss: work-up of a liver mass, symptom care, and how he wants to receive results. **S**

## Historical basis

- Sun Yat-sen was born on November 12, 1866, into an ordinary farming family in Cuiheng Village. He was called Dixiang in childhood and also had the names Mingwen, Deming and Rixin; the name Yat-sen came into use while he was in Japan. **D**
- He went to a private school at nine, studied in Honolulu from the age of thirteen, and returned home at seventeen. **D**
- He began studying Western medicine at the Boji Hospital in Guangzhou in 1886 and in 1887 transferred to the College of Medicine for Chinese in Hong Kong, as one of its twelve students; his teachers included Patrick Manson. He was one of two students who passed the graduation examination in 1892 and received his diploma at the college's first graduation ceremony on July 23, 1892. **D**
- After graduating he practiced medicine in Macau, first at the Kiang Wu Hospital and then in a dispensary of his own, and then in Guangzhou, opening pharmacies that offered Chinese and Western medicines; about two years after graduating he gave up medicine for politics. **D**
- In 1894 he founded the China Revival Society in Honolulu; in 1905 he founded the Chinese Revolutionary League in Tokyo; on New Year's Day 1912 he became Provisional President of the Republic of China in Nanjing; and in January 1924 he presided over the First National Congress of the Kuomintang in Guangzhou. **D**

6 later historical claims are omitted because they describe events after the index age. See the teaching note.

These claims are historical evidence, not findings from a real modern examination.

## History of present illness

This fictional modern episode addresses the presenting concerns below. **S**

- He has had a dull ache under his right ribs, early fullness and weight loss for three months, and can feel a firm lump there himself. **S**
- As a physician by training he wants to see his images and results himself, to be told plainly, and to be cared for on the same pathway as any other patient. **S**
- He wants to keep working and traveling for as long as he can. **S**

## Strengths and supports

- Strengths and supports: a clear, analytical mind and his own medical training; a strong sense of purpose in his work; a wide circle of colleagues **S**

## Medications and allergies

- Acetaminophen 500 mg oral tablet, two tablets by mouth every 8 hours as needed for right upper abdominal ache; no more than 3,000 mg a day **S**
- No known allergy **S**

## Past medical history

True biography with historical dates; these events are not part of the synthetic care timeline.

- No historical medical events recorded.

## Procedures and immunizations

- 2026-05-04 to 2026-05-04: Ultrasound of the abdomen **S**


## Family history

- No family medical history is documented in the logged sources. Family history of real relatives is never synthesized.

## Measurements

White cells: 7.9 10*3/uL; Hemoglobin: 12.6 g/dL (low); Platelets: 342 10*3/uL; Sodium: 137 mmol/L; Potassium: 4.2 mmol/L; Creatinine: 0.86 mg/dL; eGFR: 101 mL/min/1.73 m²; Glucose: 98 mg/dL; Albumin: 3.4 g/dL (low); Total bilirubin: 0.9 mg/dL; Alkaline phosphatase: 212 U/L (high); AST: 48 U/L (high); ALT: 41 U/L; INR: 1; Alpha-fetoprotein: 3.2 ng/mL; CA 19-9: 412 U/mL (high); CEA: 8.6 ng/mL (high); PHQ-2: 1; ECOG performance status: 1. All results are synthetic.

BP 132/84 mmHg; pulse 88 bpm; respirations 16/min; temperature 36.9 °C; oxygen saturation 98% on room air; weight 61 kg; BMI 22.4 kg/m². All vital signs are synthetic.

## Examination

Mental status: Alert, composed and precise; asks to see the ultrasound images himself; worried that the mass is a cancer; PHQ-2 1. Functional status: Independent in all activities; still works full days but tires by evening; walks 2 km without stopping. Physical examination is intentionally limited. **S**

## Assessment

1. Right upper quadrant abdominal mass with weight loss: a dull ache under the right ribs and early fullness for about three months, 4 kg weight loss, and a firm, non-tender mass felt 4 cm below the right costal margin; no jaundice, fever, or itching. Ultrasound today: a 6.8 cm solid, heterogeneous mass in liver segments IV and V that cannot be separated from the gallbladder, which contains stones; the rest of the liver is smooth, with no ascites. Multiphase CT, tumor markers, hepatitis serology and medical oncology consultation arranged; status draft. **S**

## Plan

- Work-up of the liver mass: multiphase contrast CT of the liver with CT of the chest, abdomen and pelvis; MRI of the liver with MRCP if CT does not settle the origin; alpha-fetoprotein, CA 19-9 and CEA; hepatitis B surface antigen, core antibody and surface antibody, and hepatitis C antibody; liver function with Child-Pugh and ALBI scoring; and image-guided core biopsy, because a mass in a liver without cirrhosis cannot be diagnosed by imaging alone. Guideline: NCCN Clinical Practice Guidelines in Oncology: Biliary Tract Cancers (2026); AASLD Practice Guidance on prevention, diagnosis, and treatment of hepatocellular carcinoma (2023) **S**
- Medical oncology consultation for a solid liver mass with weight loss: diagnosis, staging, multidisciplinary tumor board review, and treatment. Guideline: NCCN Clinical Practice Guidelines in Oncology: Biliary Tract Cancers (2026); AASLD Practice Guidance on prevention, diagnosis, and treatment of hepatocellular carcinoma (2023) **S**
- Symptom care during the work-up: acetaminophen up to 3,000 mg a day, small frequent meals with a dietitian's advice, weight at every visit, and a same-day call for jaundice, fever, vomiting, dark urine or worse pain; results shared with him in full as they arrive, by one coordinating clinician. Guideline: NCCN Clinical Practice Guidelines in Oncology: Biliary Tract Cancers (2026) **S**

## Guideline basis

- NCCN Clinical Practice Guidelines in Oncology: Biliary Tract Cancers (2026), National Comprehensive Cancer Network
- AASLD Practice Guidance on prevention, diagnosis, and treatment of hepatocellular carcinoma (2023), American Association for the Study of Liver Diseases (Hepatology)
